Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 2
1969 1
1970 2
1971 2
1974 2
1980 1
1987 1
2012 1
2013 1
2014 1
2016 1
2017 2
2018 1
2019 2
2020 2
2021 2
2022 3
2023 1
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination.
Zanini E, Forster-Gross N, Bachmann F, Brüngger A, McSheehy P, Litherland K, Burger K, Groner AC, Roceri M, Bury L, Stieger M, Willemsen-Seegers N, de Man J, Vu-Pham D, van Riel HWE, Zaman GJR, Buijsman RC, Kellenberger L, Lane HA. Zanini E, et al. Front Oncol. 2024 Aug 9;14:1447807. doi: 10.3389/fonc.2024.1447807. eCollection 2024. Front Oncol. 2024. PMID: 39184047 Free PMC article.
Derazantinib, a fibroblast growth factor receptor inhibitor, inhibits colony-stimulating factor receptor-1 in macrophages and tumor cells and in combination with a murine programmed cell death ligand-1-antibody activates the immune environment of murine syngeneic tumor models.
El Shemerly M, Zanini E, Lecoultre M, Walker PR, Kellenberger L, Lane HA, McSheehy PMJ. El Shemerly M, et al. Among authors: zanini e. Anticancer Drugs. 2023 Oct 1;34(9):1035-1045. doi: 10.1097/CAD.0000000000001480. Epub 2022 Dec 19. Anticancer Drugs. 2023. PMID: 36729099
Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer.
Matassa DS, Amoroso MR, Lu H, Avolio R, Arzeni D, Procaccini C, Faicchia D, Maddalena F, Simeon V, Agliarulo I, Zanini E, Mazzoccoli C, Recchi C, Stronach E, Marone G, Gabra H, Matarese G, Landriscina M, Esposito F. Matassa DS, et al. Among authors: zanini e. Cell Death Differ. 2016 Sep 1;23(9):1542-54. doi: 10.1038/cdd.2016.39. Epub 2016 May 20. Cell Death Differ. 2016. PMID: 27206315 Free PMC article.
Effectiveness of a WHO self-help psychological intervention for preventing mental disorders among Syrian refugees in Turkey: a randomized controlled trial.
Acarturk C, Uygun E, Ilkkursun Z, Carswell K, Tedeschi F, Batu M, Eskici S, Kurt G, Anttila M, Au T, Baumgartner J, Churchill R, Cuijpers P, Becker T, Koesters M, Lantta T, Nosè M, Ostuzzi G, Popa M, Purgato M, Sijbrandij M, Turrini G, Välimäki M, Walker L, Wancata J, Zanini E, White RG, van Ommeren M, Barbui C. Acarturk C, et al. Among authors: zanini e. World Psychiatry. 2022 Feb;21(1):88-95. doi: 10.1002/wps.20939. World Psychiatry. 2022. PMID: 35015365 Free PMC article.
Long-term effectiveness of Self-Help Plus in refugees and asylum seekers resettled in Western Europe: 12-month outcomes of a randomised controlled trial.
Turrini G, Purgato M, Tedeschi F, Acartürk C, Anttila M, Au T, Carswell K, Churchill R, Cuijpers P, Friedrich F, Gastaldon C, Klein T, Kösters M, Lantta T, Nosè M, Ostuzzi G, Papola D, Popa M, Sijbrandij M, Tarsitani L, Todini L, Uygun E, Välimäki M, Walker L, Wancata J, White RG, Zanini E, van Ommeren M, Barbui C. Turrini G, et al. Among authors: zanini e. Epidemiol Psychiatr Sci. 2022 Jun 8;31:e39. doi: 10.1017/S2045796022000269. Epidemiol Psychiatr Sci. 2022. PMID: 35674122 Free PMC article. Clinical Trial.
27 results